SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-043273
Filing Date
2018-08-09
Accepted
2018-08-09 16:02:35
Documents
48
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tv500125_10q.htm 10-Q 475013
2 EXHIBIT 31.1 tv500125_ex31-1.htm EX-31.1 9091
3 EXHIBIT 32.1 tv500125_ex32-1.htm EX-32.1 5460
  Complete submission text file 0001144204-18-043273.txt   5374239

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT rgrx-20180630.xml EX-101.INS 1810783
5 XBRL TAXONOMY EXTENSION SCHEMA rgrx-20180630.xsd EX-101.SCH 29897
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgrx-20180630_cal.xml EX-101.CAL 20666
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgrx-20180630_def.xml EX-101.DEF 186209
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgrx-20180630_lab.xml EX-101.LAB 213398
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgrx-20180630_pre.xml EX-101.PRE 212669
Mailing Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850 301-208-9191
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15070 | Film No.: 181004952
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences